Is there such a thing as a hair safe androgenic steroid?
Linked videos:
• Why testosterone does NOT cause hair ...
• DHT is a trash hormone part 6. Why D...
Sources:
1. Sheckter CB, Matsumoto AM, Bremner WJ. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary. J Clin Endocrinol Metab. 1989;68(2):397-401. doi:10.1210/jcem-68-2-397
2. Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi T, Uchida K. Testosterone inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Letters. 2002;530(1):129-132. doi:10.1016/S0014-5793(02)03440-3
3. Fang H, Tong W, Branham WS, et al. Study of 202 Natural, Synthetic, and Environmental Chemicals for Binding to the Androgen Receptor. Chem Res Toxicol. 2003;16(10):1338-1358. doi:10.1021/tx030011g
4. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology. 2006;55(6):1014-1023. doi:10.1016/j.jaad.2006.05.007
5. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502-521. doi:10.1038/bjp.2008.165
6. Pitteloud N, Dwyer AA, DeCruz S, et al. Inhibition of Luteinizing Hormone Secretion by Testosterone in Men Requires Aromatization for Its Pituitary But Not Its Hypothalamic Effects: Evidence from the Tandem Study of Normal and Gonadotropin-Releasing Hormone-Deficient Men. The Journal of Clinical Endocrinology & Metabolism. 2008;93(3):784-791. doi:10.1210/jc.2007-2156
7. Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities: Applied modifications in the steroidal structure. Steroids. 2009;74(2):172-197. doi:10.1016/j.steroids.2008.10.016
8. Boregowda K, Joels L, Stephens JW, Price DE. Persistent primary hypogonadism associated with anabolic steroid abuse. Fertility and Sterility. 2011;96(1):e7-e8. doi:10.1016/j.fertnstert.2011.04.029
9. Handelsman DJ. Commentary: Androgens and “Anabolic Steroids”: The One-Headed Janus. Endocrinology. 2011;152(5):1752-1754. doi:10.1210/en.2010-1501
10. Bhasin S, Travison TG, Storer TW, et al. Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production: A Randomized Controlled Trial. JAMA. 2012;307(9):931-939. doi:10.1001/jama.2012.227
11. Gallicchio L, Calhoun C, Helzlsouer KJ. Aromatase inhibitor therapy and hair loss among breast cancer survivors. Breast Cancer Res Treat. 2013;142(2):435-443. doi:10.1007/s10549-013-2744-2
12. Busardò FP, Frati P, Sanzo MD, et al. The Impact of Nandrolone Decanoate on the Central Nervous System. Curr Neuropharmacol. 2015;13(1):122-131. doi:10.2174/1570159X13666141210225822
13. Karatas F, Sahin S, Sever AR, Altundag K. Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview. Springerplus. 2016;5:585. doi:10.1186/s40064-016-2216-3
14. Pomara C, Barone R, Marino Gammazza A, et al. Effects of Nandrolone Stimulation on Testosterone Biosynthesis in Leydig Cells. J Cell Physiol. 2016;231(6):1385-1391. doi:10.1002/jcp.25272
15. Mata EFD, Nascimento AM do, Lima EM de, et al. Finasteride promotes worsening of the cardiac deleterious effects of nandrolone decanoate and protects against genotoxic and cytotoxic damage. Braz J Pharm Sci. 2020;56:e18289. doi:10.1590/s2175-97902019000318289
16. Vilar Neto J de O, da Silva CA, Bruno da Silva CA, et al. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review. Andrologia. 2021;53(7):e14062. doi:10.1111/and.14062
17. Zelleroth S, Nylander E, Kjellgren E, Grönbladh A, Hallberg M. Nandrolone decanoate and testosterone undecanoate differently affect stress hormones, neurotransmitter systems, and general activity in the male rat. Behavioural Brain Research. 2022;432:113971. doi:10.1016/j.bbr.2022.113971
18. Grandys M, Majerczak J, Frolow M, Sztefko K, Chlopicki S, Zoladz JA. Age-related decrease in serum dihydrotestosterone concentration is accompanied by impaired vascular status. Experimental Gerontology. 2023;173:112104. doi:10.1016/j.exger.2023.112104
19. Solanki P, Eu B, Smith J, Allan C, Lee K. Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review. Endocrine Connections. 2023;12(12). doi:10.1530/EC-23-0358
Watch video Is there such a thing as a hair safe androgenic steroid? online without registration, duration hours minute second in high quality. This video was added by user Haircafe 06 September 2024, don't forget to share it with your friends and acquaintances, it has been viewed on our site 9,18 once and liked it 38 people.